Precigen, Inc.
ROR-1 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

Abstract:

Provided herein are chimeric antigen receptors (CARs) for cancer therapy, and more particularly, CARs containing a scFv from an anti-ROR-1 monoclonal antibody. Provided are immune effector cells containing such CARs, and methods of treating proliferative disorders.